Established in 2001, Mycenax Biotech Inc. (Mycenax) is a company with biopharmaceutical development and manufacturing platform. We dedicate to using single-use technology in full line and pursuing to provide the cost-effective, fast speed and international quality complied CMC foundation for CDMO service. read more
Mycenax owns the first USFDA Master File registered plant in Taiwan and obtains Taiwan PIC/S GMP certification from health and welfare department in Taiwan. In addition, Mycenax's biological drug development follows ICH guidelines and meets the requirements of FDA, EMA, and AFM of Japan. Mycenax's protein-drug manufacturing process uses single-use technology, with a maximum bioreactor of 2000 liters and has accumulated more than 18 years of experience in the development of biopharmaceuticals.